Join to access to all OVN content. Join for Free
IMPOSTER: Why Do I STINK so much
Imposter syndrome overcoming self-doubt growth mindset managing inadequacy self-awareness strategies

IMPOSTER: Why Do I STINK so much


Share This Article


Summary

In this episode, Tom Caravela delves into the pervasive issue of imposter syndrome, sharing personal insights and experiences. He candidly discusses his own encounters with feelings of inadequacy and how he managed to navigate them. Tom offers practical strategies to combat imposter syndrome, emphasizing the importance of self-awareness and positive reinforcement. He encourages listeners to recognize their achievements and maintain a supportive network. The episode wraps up with Tom's final thoughts, urging the audience to engage with the community and take proactive steps towards overcoming self-doubt.

Tom Caravela, Managing Partner at The Carolan Group and Co-Founder of MSL Mastery, discusses the 5 ways to overcome imposter syndrome

Tom shares….

๐Ÿ‘‰ What is Imposter Syndrome
๐Ÿ‘‰ How can you overcome imposter syndrome
๐Ÿ‘‰ What is comparison-itis
๐Ÿ‘‰ Why should you “touch some grass”
๐Ÿ‘‰ How to develop a growth mindset

Click for Source
Imposter syndrome, overcoming self-doubt, growth mindset, managing inadequacy, self-awareness strategies

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Leverage YOUR Unique Skills for Career Advantage
Partner Avatar MSL Talk: Tom Caravela, Hahn-Ey Lee

How to Leverage YOUR Unique Skills for Career Advantage

Podcast
Business Acumen: The Other MSL Currency
Partner Avatar MSL Talk: Tom Caravela, Maria Abunto, Nabhan Islam

Business Acumen: The Other MSL Currency

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%โ€‹
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%โ€‹

Explore OVN